06.03.2013 Views

TEST LIST

TEST LIST

TEST LIST

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Analysis Method Reference range Requirement Comments<br />

Lipoprotein (a) nephelometry < 30 mg/dl<br />

serum 1 ml<br />

Lipoprotein x electrophoresis serum 1 ml<br />

Liver membrane abs. IFT serum 2 ml<br />

Liver-Kidney microsomal (LKM)<br />

abs.<br />

Lopinavir<br />

Lorazepam<br />

immunoblot serum 1 ml<br />

LC/MS minimum 1.5 - 9.5 mg/l<br />

maximum 5.2 - 14.0 mg/l<br />

HPLC therapeutic range 20 - 250 µg/l<br />

toxic > 300 µg/l<br />

Lormetazepam HPLC therapeutic range 2 - 10 µg/l<br />

Losartan<br />

Low temp. agglutinins<br />

Low temp. hemolysins<br />

Lues Activity (VDRL)<br />

LC/MS 5 - 63 µg/l<br />

agglutination < 1 : 16<br />

serum/plasma 1 ml<br />

serum 2 ml<br />

serum 2 ml<br />

serum/plasma 1 ml<br />

P: Blood to be drawn3 hrs. after oral<br />

administration of drug<br />

serum 2 ml<br />

P: Allow blood clotting at 37o C<br />

(check temperature!), spin sample,<br />

send serum, discard clot.<br />

agglutination serum 2 ml<br />

agglutination < 1 : 2<br />

P: Allow blood clotting at 37o C<br />

(check temperature!), spin sample,<br />

send serum, discard clot.<br />

serum 1 ml<br />

liquor 1 ml<br />

2x400 mg/day (Lopinavir)<br />

Biological half-life:2 hrs.<br />

Page 81

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!